ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $13,375,000 | +180.2% | 77,714 | +104.3% | 0.29% | +174.3% |
| Q2 2021 | $4,774,000 | -7.5% | 38,043 | -0.1% | 0.10% | -7.1% |
| Q1 2021 | $5,163,000 | -0.1% | 38,075 | -5.7% | 0.11% | +13.0% |
| Q4 2020 | $5,167,000 | +5.8% | 40,384 | -6.9% | 0.10% | -23.1% |
| Q3 2020 | $4,882,000 | +28.1% | 43,385 | +8.5% | 0.13% | +19.3% |
| Q2 2020 | $3,811,000 | +13.9% | 40,000 | +7.5% | 0.11% | -16.2% |
| Q1 2020 | $3,345,000 | +271.3% | 37,224 | +119.0% | 0.13% | +766.7% |
| Q4 2019 | $901,000 | +315.2% | 17,000 | +209.1% | 0.02% | +275.0% |
| Q3 2019 | $217,000 | +5.9% | 5,500 | +10.0% | 0.00% | -20.0% |
| Q2 2019 | $205,000 | -12.0% | 5,000 | 0.0% | 0.01% | -16.7% |
| Q1 2019 | $233,000 | -56.0% | 5,000 | -75.0% | 0.01% | -71.4% |
| Q1 2017 | $529,000 | +38.1% | 20,000 | +33.3% | 0.02% | +10.5% |
| Q4 2016 | $383,000 | -32.1% | 15,000 | -3.7% | 0.02% | -45.7% |
| Q3 2016 | $564,000 | +3.5% | 15,578 | -2.9% | 0.04% | -16.7% |
| Q2 2016 | $545,000 | -24.9% | 16,038 | -41.7% | 0.04% | +31.2% |
| Q1 2016 | $726,000 | -33.8% | 27,500 | +22.2% | 0.03% | -57.9% |
| Q4 2015 | $1,097,000 | +76.1% | 22,500 | -10.0% | 0.08% | +171.4% |
| Q3 2015 | $623,000 | -24.3% | 25,000 | -3.8% | 0.03% | -15.2% |
| Q2 2015 | $823,000 | +10.9% | 26,000 | +33.3% | 0.03% | 0.0% |
| Q1 2015 | $742,000 | – | 19,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |